Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 3/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9727672 | 0.91 | ABCB1 (0.43) | ABCB1MTNR1AMTNR1BHTR1ADRD2 | |
| SCHEMBL9727705 | 0.84 | ABCB1 (0.41) | ABCB1HTR1ADRD2 | |
| SCHEMBL9727737 | 0.71 | ESR1 (0.42) | — | |
| SCHEMBL4289366 | 0.71 | ABCB1 (0.55) | ABCB1MTNR1AMTNR1BLTA4HEPHX2 | |
| SCHEMBL9727633 | 0.71 | LTA4H (0.38) | ABCB1MTNR1AMTNR1BLTA4HEPHX2 | |
| SCHEMBL9727495 | 0.71 | ALDH1A1 (0.43) | — | |
| SCHEMBL14552343 | 0.69 | MAOB (0.52) | LTA4HEPHX2HTR1ADRD2 | |
| SCHEMBL4283023 | 0.68 | ABCB1 (0.54) | ABCB1LTA4HHTR1ADRD2 | |
| SCHEMBL4953923 | 0.68 | LTA4H (0.63) | ABCB1MTNR1AMTNR1BLTA4HEPHX2 | |
| SCHEMBL5758661 | 0.67 | MTNR1A (0.67) | ABCB1MTNR1AMTNR1BLTA4HEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5091533-A | Treating allergies, cardiovascular disorders, inflammation | MERCK FROSST CANADA, INC. (CA) | 1992-02-25 | — | — | US | disclosed |
| EP-0447189-A1 | 5-Hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors | MERCK FROSST CANADA INC. (CA) | 1991-09-18 | — | — | EP | disclosed |